The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study
Open accessAbstract
Learning Objectives: Explain the connection between depression and unrealistic expectations of the benefits of palliative therapy. Distinguish the trait of general hopefulness from hope for a specific favorable outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“and in cancer survivors [3, 16, 21-27]”
From A digital, coach-assisted intervention to address the psychosocial needs of young adult cancer survivors: Randomized controlled trial protocol and intervention adaptation process (2024) · cites this paper as [26]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Wright, A. A. (2008) · JAMA · doi:10.1001/jama.300.14.1665 · Cited by 2,788
Relationship between cancer patients' predictions of prognosis and their treatment preferences
Weeks, J. C. (1998) · JAMA · doi:10.1001/jama.279.21.1709 · Cited by 1,319
Gordon, A. N., Fleagle, J. T., Guthrie, D., Parkin, D. E., Gore, M. E., & Lacave, A. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3312 · Cited by 1,211
Patients’ expectations about effects of chemotherapy for advanced cancer
Weeks, J. C., Catalano, P. J., Cronin, A., Finkelman, M. D., Mack, J. W., Keating, N. L., & Schrag, D. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204410 · Cited by 1,149
Cited by
Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
Reeve, B. B., Mitchell, S. A., Dueck, A. C., Basch, E., Cella, D., Reilly, C. M., Minasian, L. M., Denicoff, A. M., O'Mara, A. M., Fisch, M. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju129 · Cited by 350
“In addition to being prevalent and important symptoms, anxiety and depression represent aspects of the cancer experience that may be worsened or improved by cancer-directed therapy, and we argue that capturing such change is relevant to trial-level interpretations of treatment benefits and burdens (46,47) and can prov…”
BackgroundImpact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future
Colombo, N., Lorusso, D., & Scollo, P. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001023 · Cited by 91
“Notwithstanding, others have questioned the utility of providing hope to patients, because if hopes are raised and not fulfilled, the false hope created may increase the risk for depression and other negative effects onwell-being.(10) This suggests that additional interventions and strategies are needed to improve com…”
BackgroundLiu, C., Liu, L., Zhang, Y., Dai, X. Z., & Wu, H. L. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0738-1 · Cited by 68
“Sjoquist KM [51] found that trait hope was negatively correlated with symptoms of depression and anxiety in ovarian cancer patients who have done chemotherapy.”
BackgroundSalamanca‐Balen, N., Merluzzi, T. V., & Chen, M. (2021) · Palliative Medicine · doi:10.1177/0269216321994728 · Cited by 57
Development of the Measure of Ovarian Symptoms and Treatment Concerns
King, M. T., Stockler, M. R., Butow, P. N., O’Connell, R. L., Voysey, M., Oza, A. M., Gillies, K., Donovan, H. S., Mercieca‐Bebber, R., Martyn, J. K., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000167 · Cited by 40
Self-citation
Metadata
- Authors
- Sjoquist, K. M., Friedlander, M. L., O'Connell, R. L., Voysey, M., King, M. T., Stockler, M. R., Oza, A. M., Gillies, K., Martyn, J. K., & Butow, P. N.
- Affiliations
- The University of Sydney (AU)
- Australian and New Zealand Gynaecological Oncology Group and National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia;
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Butow, Phyllis N.
- ORCID
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-09
- Volume
- 18
- Issue
- 11
- Pages
- 1221-1228
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- PMC
- PMC3825308
- OpenAlex
- W2103017000
- Cited by
- 43
- References
- 46
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 4 · 2015: 6 · 2014: 2
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- Australian National Health and Medical Research Council (APP570893)
- Ovarian Cancer Research Foundation
- Topics
- Social Sciences › Psychology › Applied Psychology › Optimism, Hope, and Well-being
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- trait hope, platinum-resistant ovarian cancer, recurrent ovarian cancer, chemotherapy, perceived treatment effectiveness, depression, anxiety, quality of life, patient expectations
- MeSH terms
- Carcinoma, Ovarian Epithelial, Adult, Aged, Aged, 80 and over, Anxiety, Depression, Female, Humans, Longitudinal Studies, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Glandular and Epithelial, Organoplatinum Compounds, Ovarian Neoplasms, Prognosis, Quality of Life, Surveys and Questionnaires, Treatment Outcome, Drug Resistance, Neoplasm, Hope
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study. https://app.cochat.ai/papers/10.1634/theoncologist.2013-0175
- The paper
- Sjoquist, K. M., Friedlander, M. L., O'Connell, R. L., Voysey, M., King, M. T., Stockler, M. R., Oza, A. M., Gillies, K., Martyn, J. K., & Butow, P. N. (2013). Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study. The Oncologist. https://doi.org/10.1634/theoncologist.2013-0175
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.